Catalyst Wire Dossier Catalyst Wire Dossier

SHR20004 (Noiiglutide)

Noiiglutide · Jiangsu HengRui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR20004 (Noiiglutide), covering 2022-03-15 to 2022-03-15. Get the full timeline:

Most recent: Clinical Trial Update: The Effect of SHR20004(Noiiglutide ) on Body Weight in Obese Subjects Without Diabetes [Phase 2]

See pricing